UNIQURE NV's ticker is QURE and the CUSIP is N90064101. A total of 187 filers reported holding UNIQURE NV in Q4 2019. The put-call ratio across all filers is 0.31 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $272,000 | -43.8% | 14,492 | -44.2% | 0.04% | -34.0% |
| Q2 2022 | $484,000 | -3.0% | 25,967 | -5.9% | 0.05% | 0.0% |
| Q1 2022 | $499,000 | +20.0% | 27,607 | +37.5% | 0.05% | +20.5% |
| Q4 2021 | $416,000 | -31.1% | 20,079 | +6.5% | 0.04% | -34.3% |
| Q3 2021 | $604,000 | +9.0% | 18,858 | +4.9% | 0.07% | +9.8% |
| Q2 2021 | $554,000 | -36.3% | 17,975 | -30.4% | 0.06% | -53.1% |
| Q1 2021 | $870,000 | +45.0% | 25,815 | +55.5% | 0.13% | +21.5% |
| Q4 2020 | $600,000 | +76.0% | 16,603 | +79.3% | 0.11% | +50.7% |
| Q3 2020 | $341,000 | +1.2% | 9,259 | +11.9% | 0.07% | -1.4% |
| Q2 2020 | $337,000 | -18.2% | 8,275 | +13.6% | 0.07% | -33.9% |
| Q1 2020 | $412,000 | -0.7% | 7,285 | +8.7% | 0.11% | +11.2% |
| Q4 2019 | $415,000 | – | 6,699 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 841,471 | $15,786,000 | 5.69% |
| Nantahala Capital Management | 2,901,929 | $54,440,000 | 3.52% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 544,500 | $10,209,000 | 3.27% |
| 683 Capital Management, LLC | 1,373,600 | $25,768,000 | 1.99% |
| PFM Health Sciences, LP | 2,393,311 | $44,899,000 | 1.62% |
| Integral Health Asset Management, LLC | 433,000 | $8,123,000 | 1.58% |
| Privium Fund Management B.V. | 238,998 | $4,283,000 | 1.56% |
| Nantahala Capital Management | 1,000,000 | $18,760,000 | 1.21% |
| Henry James International Management Inc. | 89,469 | $1,678,000 | 0.94% |
| Altium Capital Management LP | 105,000 | $1,970,000 | 0.72% |